Products

Aigc160

AI Content Tools for Writing, Images, Video, and Creative Work

aigc160.com Entertainment & Media / Directories & Curated Lists

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Jesus Camacho
No social account linked
Launched
14mo ago
2025-09-24 · Est.

Traffic

Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Fazier (#125 · 40 upvotes · 27 comments)Launch

    AIGC 160 — Create Smarter. Explore Further.

    Oct 8 · 38d agoLaunch page

    At the time: <5K visits/mo
  • Launched on Product HuntLaunch

    Create Smarter. Explore Further.

    Sep 27, 2025 · 14mo agoLaunch page

  • Launched on IndiePageLaunch

    Aigc160

    Sep 24, 2025 · 14mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-07-03

KeywordMonthly volume
free chinese websites for ai video generation—

Traffic data: Vaneform

Pricing

Pricing page does not list plan prices.

Trial: None · Observed 2026-11-09 · Pricing page

Pages & changes

Tracked since 2026-09-15

Key pages

Weekly snapshots
aigc160.com/ Snapshot 2026-11-09

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Aigc160 get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Aigc160 and what platforms does it support?
Aigc160 is catalogued under Directories & Curated Lists: AI Content Tools for Writing, Images, Video, and Creative Work. Supported platforms: Web.

Related products in this category

Entertainment & Media / Directories & Curated Lists

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.